Stockscreener 앱 받기
3.38
5.06%
-0.18
시간 외 거래:
3.31
-0.07
-2.07%
Endra Life Sciences Inc 주식(NDRA)의 최신 뉴스
Ascendiant Capital Maintains Buy Rating on ENDRA Life Sciences (NDRA) | NDRA Stock News - GuruFocus
Microchip Technology To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
ENDRA Life Sciences Faces Nasdaq Compliance Challenge - TipRanks
ENDRA Life Sciences: Strategic Shift and Financial Update - TipRanks
ENDRA Life Sciences Provides a Business Update and Reports First - GuruFocus
ENDRA Life Sciences (NDRA) Aims to Revolutionize Metabolic Disease Detection | NDRA Stock News - GuruFocus
ENDRA Life Sciences Q1 2025 Financial Results and Business Update - TradingView
ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView
ENDRA Life Sciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Endra Life Sciences reports Q1 EPS ($1.86) vs ($449.58) last year - TipRanks
ENDRA Life Sciences Provides A Business Update And Reports First Quarter 2025 Financial Results - marketscreener.com
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results - Stock Titan
ENDRA Life Sciences (NDRA) to Release Quarterly Earnings on Tuesday - Defense World
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Short Interest Update - The AM Reporter
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Sees Significant Growth in Short Interest - Defense World
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Highs and Lows in the Market - investchronicle.com
What is ENDRA Life Sciences Inc (NDRA) Stock Return on Shareholders’ Capital? - Sete News
What Are You Thinking About Investing In ENDRA Life Sciences Inc (NASDAQ: NDRA) Stock? - Stocksregister
ENDRA Life Sciences Inc: Navigating Market Fluctuations with a 1.74M Market Cap - investchronicle.com
Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket - Benzinga
ENDRA Life Sciences Deploys TAEUS Tech to Improve Metabolic Disease Detection - Medical Product Outsourcing
A Guide To The Risks Of Investing In ENDRA Life Sciences Inc (NDRA) - knoxdaily.com
ENDRA Life Sciences (NASDAQ:NDRA) Given New $50.00 Price Target at Ascendiant Capital Markets - Defense World
NDRA stock touches 52-week low at $3.05 amid sharp annual decline By Investing.com - Investing.com South Africa
NDRA stock touches 52-week low at $3.05 amid sharp annual decline - Investing.com India
Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ENDRA Life Sciences Stock Gains Market Momentum - Stocks Telegraph
ENDRA Life Sciences Advances TAEUS Liver Device Strategy - TipRanks
ENDRA Life Sciences pivots to metabolic health market - Investing.com
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartz
ENDRA Life Sciences Inc. SEC 10-K Report - TradingView
How ENDRA's AI-Powered Device Could Transform GLP-1 Weight Loss Treatment Monitoring - Stock Titan
ENDRA Slashes Monthly Expenses 37% as TAEUS Liver Device Advances - Stock Titan
ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update - Business Wire
ENDRA Life Sciences Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView
ENDRA Life Sciences (NDRA) Projected to Post Earnings on Thursday - Defense World
ENDRA Life Sciences Strengthens TAEUS® System Intellectual Property with Issuance of 24th U.S. Patent - Business Wire
ENDRA Life Sciences stock hits 52-week low at $3.89 amid steep decline - Investing.com Canada
ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland - ACCESS Newswire
Critical Contrast: ENDRA Life Sciences (NASDAQ:NDRA) vs. Gadsden Properties (OTCMKTS:GADS) - Defense World
ENDRA Life Sciences to Participate at Upcoming Investor Conferences - ACCESS Newswire
ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe - ACCESS Newswire
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue - ACCESS Newswire
Where are the Opportunities in (NDRA) - Stock Traders Daily
What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock - MSN
Financial Contrast: NeurAxis (NASDAQ:NRXS) versus ENDRA Life Sciences (NASDAQ:NDRA) - Defense World
(NDRA) On The My Stocks Page - Stock Traders Daily
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
(NDRA) Trading Signals - Stock Traders Daily
Study Highlighting ENDRA Life Sciences TAEUS Technology in Patients with High BMI to be presented at AASLD's The Liver Meeting 2024 - Marketscreener.com
Data I/O And 2 Other Stocks Under $5 Executives Are Buying - MSN
(NDRA) Technical Data - Stock Traders Daily
ENDRA Life Sciences meets Nasdaq listing standards - Investing.com Australia
ENDRA Life Sciences Regains Nasdaq Compliance, Clears Path for Strategic Growth - Stock Titan
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
NDRA stock touches 52-week low at $5.23 amid sharp annual decline - Investing.com
0.09%
자본화:
|
볼륨(24시간):